Literature DB >> 18269928

Non-IgE-mediated chronic allergic skin inflammation revealed with rBet v 1 fragments.

Raffaela Campana, Nadine Mothes, Ingrid Rauter, Susanne Vrtala, Renate Reininger, Margarete Focke-Tejkl, Christian Lupinek, Nadja Balic, Susanne Spitzauer, Rudolf Valenta.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18269928     DOI： 10.1016/j.jaci.2007.09.014

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  17 in total

Review 1.  Novel vaccines: Technology and development.

Authors:  Sarita U Patil; Wayne G Shreffler
Journal:  J Allergy Clin Immunol       Date:  2018-06-30       Impact factor: 10.793

Review 2.  How Do Pollen Allergens Sensitize?

Authors:  Svetlana V Guryanova; Ekaterina I Finkina; Daria N Melnikova; Ivan V Bogdanov; Barbara Bohle; Tatiana V Ovchinnikova
Journal:  Front Mol Biosci       Date:  2022-06-16

3.  A nonallergenic birch pollen allergy vaccine consisting of hepatitis PreS-fused Bet v 1 peptides focuses blocking IgG toward IgE epitopes and shifts immune responses to a tolerogenic and Th1 phenotype.

Authors:  Katharina Marth; Isabella Breyer; Margarete Focke-Tejkl; Katharina Blatt; Mohamed H Shamji; Janice Layhadi; Anna Gieras; Ines Swoboda; Domen Zafred; Walter Keller; Peter Valent; Stephen R Durham; Rudolf Valenta
Journal:  J Immunol       Date:  2013-02-25       Impact factor: 5.422

Review 4.  Mechanisms underlying allergy vaccination with recombinant hypoallergenic allergen derivatives.

Authors:  Birgit Linhart; Rudolf Valenta
Journal:  Vaccine       Date:  2011-11-17       Impact factor: 3.641

5.  Carrier-bound nonallergenic Der p 2 peptides induce IgG antibodies blocking allergen-induced basophil activation in allergic patients.

Authors:  K-W Chen; M Focke-Tejkl; K Blatt; M Kneidinger; A Gieras; F Dall'Antonia; I Faé; G Fischer; W Keller; P Valent; R Valenta; S Vrtala
Journal:  Allergy       Date:  2012-02-17       Impact factor: 13.146

6.  Frequent occurrence of T cell-mediated late reactions revealed by atopy patch testing with hypoallergenic rBet v 1 fragments.

Authors:  Raffaela Campana; Katharina Moritz; Katharina Marth; Angela Neubauer; Hans Huber; Rainer Henning; Katharina Blatt; Gregor Hoermann; Tess M Brodie; Alexandra Kaider; Peter Valent; Federica Sallusto; Stefan Wöhrl; Rudolf Valenta
Journal:  J Allergy Clin Immunol       Date:  2015-10-28       Impact factor: 10.793

Review 7.  Molecular aspects of allergens in atopic dermatitis.

Authors:  Raffaela Campana; Sheron Dzoro; Irene Mittermann; Elena Fedenko; Olga Elisyutina; Musa Khaitov; Alexander Karaulov; Rudolf Valenta
Journal:  Curr Opin Allergy Clin Immunol       Date:  2017-08

Review 8.  Food allergies: the basics.

Authors:  Rudolf Valenta; Heidrun Hochwallner; Birgit Linhart; Sandra Pahr
Journal:  Gastroenterology       Date:  2015-02-11       Impact factor: 22.682

Review 9.  Recombinant allergen-based provocation testing.

Authors:  Verena Niederberger; Julia Eckl-Dorna; Gabrielle Pauli
Journal:  Methods       Date:  2013-08-03       Impact factor: 3.608

Review 10.  Allergen Peptides, Recombinant Allergens and Hypoallergens for Allergen-Specific Immunotherapy.

Authors:  Katharina Marth; Margarete Focke-Tejkl; Christian Lupinek; Rudolf Valenta; Verena Niederberger
Journal:  Curr Treat Options Allergy       Date:  2014-02-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.